Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.

Harel Z, Biro FM, Kollar LM, Rauh JL.

J Adolesc Health. 1996 Aug;19(2):118-23.

PMID:
8863083
2.

Contraception in the adolescent patient.

Tafelski T, Boehm KE.

Prim Care. 1995 Mar;22(1):145-59. Review.

PMID:
7777635
3.

Depo Provera. Position paper on clinical use, effectiveness and side effects.

Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.

Br J Fam Plann. 1999 Jul;25(2):69-76. Review. Erratum in: Br J Fam Plann 2000 Jan;26(1):52-3.

PMID:
10454658
4.

The use of Norplant and Depo Provera in adolescents.

Ammerman SD.

J Adolesc Health. 1995 May;16(5):343-6. Review.

PMID:
7662681
5.

Injectable and implantable contraceptives.

Cullins VE.

Curr Opin Obstet Gynecol. 1992 Aug;4(4):536-43. Review.

PMID:
1387011
6.

Vaginal bleeding patterns in women using once-a-month injectable contraceptives.

Fraser IS.

Contraception. 1994 Apr;49(4):399-420. Review.

PMID:
8013222
7.

Long-acting contraceptive options.

Kaunitz AM.

Int J Fertil Menopausal Stud. 1996 Mar-Apr;41(2):69-76. Review.

PMID:
8829701
8.

Adolescent contraception.

Polaneczky M.

Curr Opin Obstet Gynecol. 1998 Jun;10(3):213-9. Review.

PMID:
9619344
9.

Long-acting hormonal contraception: assessing impact on bone density, weight, and mood.

Kaunitz AM.

Int J Fertil Womens Med. 1999 Mar-Apr;44(2):110-7. Review.

PMID:
10338269
10.

Use of depot medroxyprogesterone acetate contraception in adolescents.

Davis AJ.

J Reprod Med. 1996 May;41(5 Suppl):407-13. Review.

PMID:
8725703
11.

Use of depo-provera in teens.

Khoiny FE.

J Pediatr Health Care. 1996 Sep-Oct;10(5):195-201. Review.

PMID:
8920351
12.

New contraceptive options for adolescents.

Neal W, Coupey SM.

Compr Ther. 1997 Jul;23(7):439-45. Review.

PMID:
9262918
13.

Nondaily hormonal contraception: considerations in contraceptive choice and patient counseling.

Freeman S.

J Am Acad Nurse Pract. 2004 Jun;16(6):226-38. Review.

PMID:
15264608
14.

Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk.

Kahn HS, Curtis KM, Marchbanks PA.

Diabetes Care. 2003 Jan;26(1):216-25. Review.

PMID:
12502684
15.

Depot-medroxyprogesterone acetate: an update.

Bakry S, Merhi ZO, Scalise TJ, Mahmoud MS, Fadiel A, Naftolin F.

Arch Gynecol Obstet. 2008 Jul;278(1):1-12. doi: 10.1007/s00404-007-0497-z. Epub 2008 May 10. Review.

PMID:
18470526
16.

Subdermal contraceptive implants in nurse-midwifery practice.

Emerling JM, Paluzzi P, Leiva J, Cullins VE.

J Nurse Midwifery. 1993 Mar-Apr;38(2 Suppl):80S-87S. Review.

PMID:
8483013
17.

Considerations for the use of progestin-only contraceptives.

Freeman S, Shulman LP.

J Am Acad Nurse Pract. 2010 Feb;22(2):81-91. doi: 10.1111/j.1745-7599.2009.00473.x. Review.

PMID:
20132366
18.

[Contraception with depot gestagens].

Koryntová D, Cepický P, Zivný J.

Ceska Gynekol. 2001 May;66(3):202-8. Review. Czech.

PMID:
11464383
19.

[Contraception with injectable long-acting preparation depo-provera].

Prilepskaia VN, Kondrikov NI, Tagieva TT.

Akush Ginekol (Mosk). 1995;(3):7-10. Review. Russian.

PMID:
7653732
20.

Menstruation and its disorders in adolescence.

Greydanus DE, McAnarney ER.

Curr Probl Pediatr. 1982 Aug;12(10):1-61. Review.

PMID:
6764754

Supplemental Content

Support Center